Logo image of ALESA.PA

ECOSLOPS (ALESA.PA) Stock Fundamental Analysis

EPA:ALESA - Euronext Paris - Matif - FR0011490648 - Common Stock - Currency: EUR

0.85  +0.07 (+9.25%)

Fundamental Rating

2

Overall ALESA gets a fundamental rating of 2 out of 10. We evaluated ALESA against 41 industry peers in the Commercial Services & Supplies industry. ALESA has a bad profitability rating. Also its financial health evaluation is rather negative. ALESA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALESA has reported negative net income.
In the past 5 years ALESA always reported negative net income.
In the past 5 years ALESA always reported negative operating cash flow.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of ALESA (-11.55%) is worse than 78.05% of its industry peers.
ALESA's Return On Equity of -61.57% is on the low side compared to the rest of the industry. ALESA is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
ROA -11.55%
ROE -61.57%
ROIC N/A
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 66.05%, ALESA is doing good in the industry, outperforming 70.73% of the companies in the same industry.
ALESA's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALESA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALESA has about the same amount of shares outstanding.
The number of shares outstanding for ALESA has been increased compared to 5 years ago.
Compared to 1 year ago, ALESA has a worse debt to assets ratio.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ALESA has an Altman-Z score of -1.38. This is a bad value and indicates that ALESA is not financially healthy and even has some risk of bankruptcy.
ALESA's Altman-Z score of -1.38 is on the low side compared to the rest of the industry. ALESA is outperformed by 80.49% of its industry peers.
ALESA has a Debt/Equity ratio of 2.73. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.73, ALESA is doing worse than 80.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.73
Debt/FCF N/A
Altman-Z -1.38
ROIC/WACCN/A
WACCN/A
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALESA has a Current Ratio of 1.81. This is a normal value and indicates that ALESA is financially healthy and should not expect problems in meeting its short term obligations.
ALESA has a Current ratio of 1.81. This is in the better half of the industry: ALESA outperforms 75.61% of its industry peers.
A Quick Ratio of 1.49 indicates that ALESA should not have too much problems paying its short term obligations.
The Quick ratio of ALESA (1.49) is better than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.49
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

ALESA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.92%, which is quite impressive.
Looking at the last year, ALESA shows a quite strong growth in Revenue. The Revenue has grown by 12.05% in the last year.
ALESA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.43% yearly.
EPS 1Y (TTM)57.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.74%
Revenue 1Y (TTM)12.05%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%12.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALESA. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 1.67 indicates a rather cheap valuation of ALESA.
Based on the Price/Forward Earnings ratio, ALESA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.04, ALESA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.67
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

ALESA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALESA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECOSLOPS

EPA:ALESA (8/8/2025, 7:00:00 PM)

0.85

+0.07 (+9.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-17 2025-07-17
Earnings (Next)N/A N/A
Inst Owners12.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.41M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.67
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-0.6
EYN/A
EPS(NY)0.51
Fwd EY59.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.22
BVpS0.97
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.55%
ROE -61.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.05%
FCFM N/A
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 2.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.49
Altman-Z -1.38
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.74%
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.05%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%12.74%
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1271.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A